or Try an Advanced Search...

    Technical Analysis for TLX - Telix Pharmaceuticals Ltd  

    Grade Last Price % Change Price Change
    B 12.540 0.00% 0.000
    TLX closed unchanged on Thursday, April 18, 2024, on 2.63 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    4 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Down
    Historical TLX trend table...
    Date Alert Name Type % Chg
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Fell Below 20 DMA Bearish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    BB Squeeze + Lower Band Touch Range Contraction 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Older End-of-Day Signals for TLX ...

       Recent Intraday Alerts

    Alert Time
    Possible Pocket Pivot about 23 hours ago
    Up 10% about 24 hours ago
    New 52 Week High about 24 hours ago
    Up 2 ATRs about 24 hours ago
    3x Volume Pace about 24 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    TLX Chart by TradingView
    Basic chart:

    Profile

    Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company. The Company is focused on development and commercialization of diagnostic and therapeutic products based on radiopharmaceuticals, or molecularly-targeted radiation (MTR). MTR is a novel therapeutic approach that selectively delivers radiation to cells that exhibit certain molecular profiles or targets that may be indicative of cancer. The Company's MTR products such as TLX-250 diagnosis and treatment of renal (kidney), TLX-591 treatment of metastatic castrate-resistant prostate cancer, and TLX-101 treatment of glioblastoma (brain cancer).
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Natural Sciences Medicine Pharmaceutical Cancer Radio Drugs Pharmaceuticals Biopharmaceutical Therapeutic Product Profile Therapeutic Products Radiation Prostate Cancer Radiation Therapy Radiopharmaceuticals Brain Cancer Glioblastoma Radioactivity Radiopharmaceutical

    Is TLX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 17 Q1 2024 Revenue and Business Update
    Apr 16 QSAM ANNOUNCES REVERSE STOCK SPLIT RATIO AHEAD OF MERGER
    Apr 15 TLX101-CDx (Pixclara™) Granted FDA Fast Track Designation
    Apr 11 Telix Pharmaceuticals Limited completes the acquisition of ARTMS, Inc.
    Mar 26 World First Use of Lightpoint's SENSEI® Drop-In Gamma Probe in Bladder Cancer Surgery Performed in Spain
    Mar 18 QDOSE® Platform Partnership for Personalised Dosimetry in Radiopharmaceutical Therapy
    Mar 18 QDOSE® Platform Partnership for Personalized Dosimetry in Radiopharmaceutical Therapy
    Mar 11 Appointment of Dr Darren Patti to Group Chief Operating Officer
    Mar 4 Telix to Acquire ARTMS, Inc. and its Advanced Isotope Production Platform
    Feb 26 Telix Expands U.S. Development and Manufacturing Infrastructure with Acquisition of IsoTherapeutics
    See more TLX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 13.54
    52 Week Low 8.2
    Average Volume 1,169,817
    200-Day Moving Average 10.794
    50-Day Moving Average 11.993
    20-Day Moving Average 12.621
    10-Day Moving Average 12.604
    Average True Range 0.494
    RSI (14) 52.83
    ADX 15.73
    +DI 24.123
    -DI 24.272
    Chandelier Exit (Long, 3 ATRs) 12.059
    Chandelier Exit (Short, 3 ATRs) 13.301
    Upper Bollinger Bands 13.170
    Lower Bollinger Band 12.071
    Percent B (%b) 0.43
    BandWidth 8.702
    MACD Line 0.191
    MACD Signal Line 0.225
    MACD Histogram -0.034
    Fundamentals Value
    Market Cap 3.46 Billion
    Num Shares 276 Million
    EPS -0.09
    Price-to-Earnings (P/E) Ratio -140.90
    Price-to-Sales 214.62
    Price-to-Book 14.38
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 12.540
    Resistance 3 (R3) 12.540 12.540 12.540
    Resistance 2 (R2) 12.540 12.540 12.540 12.540
    Resistance 1 (R1) 12.540 12.540 12.540 12.540 12.540
    Pivot Point 12.540 12.540 12.540 12.540 12.540
    Support 1 (S1) 12.540 12.540 12.540 12.540 12.540
    Support 2 (S2) 12.540 12.540 12.540 12.540
    Support 3 (S3) 12.540 12.540 12.540
    Support 4 (S4) 12.540